Unlicensed Specials – Medicines made by manufacturers under a “Specials” licence. In the UK it is expected that medicines, being supplied and available to the public have been subject to clinical trials and hold marketing authorisation or a license that has been granted by the MHRA (Medicines & Healthcare Products Regulatory Agency). The use of licensed medicines protects and maximizes patients’ safety and minimizes potential liability.
However, sometimes there are no suitable licensed products available for a patient’s specific clinical need and there are times when Unlicensed Medicines (ULM) are prescribed & dispensed.
Pharmacy staff regularly obtain and supply unlicensed ‘special’ medicines. However, compared to licensed medicines there are less well-defined parameters for the safe and effective use of ULM’s and have been associated with increased risks.
Join us for the Pharmacy Consulting Monthly RP Forum where we will be discussing ‘Unlicenced Specials’. Guaranteed to have experienced RP Consultants on every forum. Ask your questions? Provide and share experiences in a controlled manner to increase your knowledge pool and keep your industry knowledge up to date.
When: 8th March 2022 @ 10:00 am
Time: 1hr
Cost: £25.00 + VAT
These forums are intended for operational RPs and quality departments focusing on aspects of the RP role, quality challenges and operation difficulties within the pharmaceutical distribution sector. All our forums will include a digital quick reference guide on the topic and a certificate of attendance.
Keep your vital industry knowledge up to date
Reference: https://ncbi.nlm.nih.gov/pmc/articles/PMC7431448/